Be a light of hope this holiday season. Ignite more progress, restore more freedom, and inspire more hope for families living with neuromuscular disease.

Innovations in Care

We provide access to support and programs that empower the lives of people living with neuromuscular diseases.

MDA Learning Series: Myasthenia Gravis

June 11th, 2024
4:30-7:00pm Eastern time
On-Demand Webinar

Watch on Demand

This MDA Virtual Learning Series aims to provide relevant, up-to-date information on care, research advancements, and support for people living with myasthenia gravis (MG) and their caregivers. Learners will receive information and resources to help navigate daily life and care decisions. Presentations will include:

  • Advances in Research and Care for MG
    Srikanth Muppidi, MD
    Stanford University
  • Managing Your Medication in MG
    Claire Spahn, Pharm D
    Stanford University
  • Treatment expectations: Setting the bar for a life without symptoms
    Jeffrey Rosenfeld PhD., MD, FAAN
    Loma Linda University School of Medicine
  • Special Considerations for Children with MG
    Leslie Delfiner, MD
    Montefiore Medical Center

Attendees will have the opportunity to ask questions during the live Q&A after each presentation.

There is no cost to MDA community members or healthcare providers to attend the event, but registration is required.

Unable to attend on June 11 or 12? This series will be recorded for on-demand viewing. Please continue with registering even if you cannot attend to ensure you receive an email with the link to the recording. The recording will be available approximately 3-4 weeks after the live program.

If you have questions about this learning series or any other Community Education programs, please reach out to the MDA Resource Center at 1-833-ASK-MDA1 (275-6321) or ResourceCenter@mdausa.org.

Members of the biopharma industry interested in sponsoring or attending should contact the MDA Healthcare Partnerships team at MDAPartners@mdausa.org.


Thank you to our supporters:

AlexionArgenxGenentechUCB Community Health Fund